Table 2.

Efficacy Results.

Efficacy End Point	CT-PFNECII + Chemotherapy (n = 17)			Chemotherapy (n = 17)			P	Hazard Ratio	95% CI
	No.	%	95% CI	No.	%	95% CI
OS, mo
Median	9.5		7.91-10.49	5.3		3.66-6.94	.004	.29	.11-.80
PFS, mo
Median	5.4		4.30-6.70	3.0		2.23-3.77	.001	.26	.15-.76
Range	0-10			0-7
Best overall response⁎							.024#
CR	1			0
PR	3			2
SD	6			4
PD	7			11
ORR (CR+PR)	4	23.53		2	11.76		.000⁎
DCR (CR+PR+SD at first tumor assessment)	10	58.82		6	35.29		.000⁎

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.

n = 17 for each group.

^⁎χ² test.

^#Ridit analysis.